Counselors in Wildwood, GA Accepting Medicare
3 Counselors found. Showing 1 - 3
 Abigail White, CSC, CADC-II Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1236 Highway 299, Wildwood, GA 30757 Phone: 423-428-0045 |
Abrianna Mcgill, RAS II, CSC, GCADC-I Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1236 Highway 299, Wildwood, GA 30757 Phone: 423-428-0045 |
Lisa Edwards, CSC, GCADC-I, MRAS Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1236 Highway 299, Wildwood, GA 30757 Phone: 423-428-0045 |
News Archive
Rapid and sensitive tracking of fat molecules in the body
Fats have earned a bad name as the source of all that is wrong with our hearts and blood vessels, not to mention our appearance. The dysfunctional handling of lipids or fats in the body is deeply involved in a multitude of metabolic upsets, such as obesity and cancer.
Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF
Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials.
Eastern Europe, Latin America and Asia are new regions for clinical trials
Aon Corporation, the leading global provider of risk management services, insurance and reinsurance brokerage, and human capital consulting, today issued the findings of its 2009 Clinical Trials Risk Map to address the constantly changing environment in which biotechnology, pharmaceutical and medical device companies conduct business around the world.
START proteins could help treat cholesterol build-up in arteries: Report
A newly discovered group of proteins could help treat cholesterol build-up in arteries. This build-up leads to atherosclerosis or 'hardening of the arteries', and the resulting condition, coronary heart disease, kills an estimated 124,000 each year in England and Wales.
Impax Laboratories, IGI Laboratories announce product development and supply agreement
Impax Laboratories, Inc. today announced that it has entered into a product development and supply agreement with IGI Laboratories, Inc., a formulation and manufacturing company. IGI will be responsible for developing two topical drug products, obtaining FDA marketing approvals, and manufacturing the commercial products.
› Verified 4 days ago